PB 104 of 2023
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 1) 2023
I, Nikolai Tsyganov, as delegate of the Minister for Health and Aged Care, make the following Determination.
Dated 3 October 2023
Nikolai Tsyganov
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
1 Name
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments—General
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023
5 Floor price of certain brands of pharmaceutical items
Schedule 2—Amendments—Additional designated brands effective from 1 April 2024
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023
Schedule 3—Repeals
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2022
1 Name
(1) This instrument is the National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 1) 2023.
(2) This instrument may also be cited as PB 104 of 2023.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. Sections 1 to 4 and anything in this instrument not elsewhere covered by this table | The day after this instrument is registered. |
|
2. Schedule 1 | The day after this instrument is registered. |
|
3. Schedule 2 | 1 April 2024. | 1 April 2024 |
4. Schedule 3 | The day after this instrument is registered. |
|
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsection 99ADHC(2) of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments—General
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023
1 Section 5
Repeal the section, substitute:
5 Floor price of certain brands of pharmaceutical items
For the purposes of subsection 99ADHC(2) of the Act, paragraph 99ADHC(1)(c) of the Act applies to a brand mentioned in column 1 of an item in the following table of a pharmaceutical item that is the drug mentioned in column 2 of that table item, in the form mentioned in column 3 of that table item and with the manner of administration mentioned in column 4 of that table item.
Floor price of certain brands of pharmaceutical items | |||
Column 1 | Column 2 | Column 3 | Column 4 |
PKU squeezie | Amino acid formula with vitamins and minerals without phenylalanine | Oral gel 85 g, 30 (PKU squeezie) | Oral |
Cal-500 | Calcium | Tablet, chewable, 500 mg (as carbonate) | Oral |
Dantrium | Dantrolene | Capsule containing dantrolene sodium hemiheptahydrate 25 mg | Oral |
DBL Desferrioxamine Mesilate | Desferrioxamine | Powder for injection containing desferrioxamine mesilate 2 g | Injection |
Cardizem | Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral |
Diltiazem AN | Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral |
Vasocardol | Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral |
Triumeq | Dolutegravir with abacavir and lamivudine | Tablet containing dolutegravir 50 mg with abacavir 600 mg and lamivudine 300 mg | Oral |
Flucil | Flucloxacillin | Powder for injection 1 g (as sodium monohydrate) | Injection |
Flucil | Flucloxacillin | Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
Flucil | Flucloxacillin | Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
DBL Heparin Sodium | Heparin | Injection 5,000 units (as sodium) in 0.2 ml | Injection |
Moduretic | Hydrochlorothiazide with amiloride | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | Oral |
Hymenoptera Honey Bee Venom | Insect allergen extract-honey bee venom | Injection set containing 550 micrograms with diluent | Injection |
Hymenoptera Paper Wasp Venom | Insect allergen extract-paper wasp venom | Injection set containing 550 micrograms with diluent | Injection |
Hymenoptera Yellow Jacket Venom | Insect allergen extract-yellow jacket venom | Injection set containing 550 micrograms with diluent | Injection |
Toujeo Solostar | Insulin glargine | Injections (human analogue), cartridge, 300 units per mL, 1.5 mL, 3 | Injection |
Toujeo Solostar | Insulin glargine | Injections (human analogue), cartridges, 300 units per mL, 1.5 mL, 5 | Injection |
Lithicarb | Lithium | Tablet containing lithium carbonate 250 mg | Oral |
Quilonum SR | Lithium | Tablet containing lithium carbonate 450 mg (slow release) | Oral |
Penthrox | Methoxyflurane | Liquid for inhalation 999 mg per g, 3 ml (with inhaler) | Inhalation by mouth |
Lyclear | Permethrin | Cream 50 mg per g, 30 g | Application |
Pro-Cid | Probenecid | Tablet 500 mg | Oral |
Asmol CFC-Free with dose counter | Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth |
Ventolin CFC-Free with dose counter | Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth |
Zempreon CFC-Free with dose counter | Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth |
PHOSPHATE PHEBRA | Sodium acid phosphate | Tablet, compound effervescent, equivalent to 500 mg phosphorus | Oral |
Lipistart | Triglycerides - medium chain, formula | Oral powder 400 g (Lipistart) | Oral |
K.Quik | Triglycerides, medium chain | Oral liquid 225 mL, 15 (K.Quik) | Oral |
Schedule 2—Amendments—Additional designated brands effective from 1 April 2024
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023
1 Section 5 (after table item dealing with the brand PKU squeezie of the drug Amino acid formula with vitamins and minerals without phenylalanine in the form Oral gel 85 g, 30 (PKU squeezie))
Insert:
Kineret | Anakinra | Injection 100 mg in 0.67 mL single use pre-filled syringe | Injection |
Bicillin L-A | Benzathine benzylpenicillin | Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre-filled syringe | Injection |
Bicillin L-A | Benzathine benzylpenicillin | Injection containing 600,000 units benzathine benzylpenicillin tetrahydrate in 1.17 mL single use pre-filled syringe | Injection |
2 Section 5 (after table item dealing with the brand Vasocardol of the drug Diltiazem in the form Tablet containing diltiazem hydrochloride 60 mg)
Insert:
ADT Booster | Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre-filled syringe | Injection |
3 Section 5 (after table item dealing with the brand Triumeq of the drug Dolutegravir with abacavir and lamivudine in the form Tablet containing dolutegravir 50 mg with abacavir 600 mg and lamivudine 300 mg)
Insert:
Estraderm MX 50 | Estradiol | Transdermal patches 1.5 mg (as hemihydrate), 8 | Transdermal |
Estraderm MX 100 | Estradiol | Transdermal patches 3 mg (as hemihydrate), 8 | Transdermal |
Estraderm MX 25 | Estradiol | Transdermal patches 750 micrograms (as hemihydrate), 8 | Transdermal |
4 Section 5 (after table item dealing with the brand Quilonum SR of the drug Lithium in the form Tablet containing lithium carbonate 450 mg (slow release))
Insert:
OsmoLax | Macrogol 3350 | Powder for oral solution 510 g | Oral |
5 Section 5 (after table item dealing with the brand Penthrox of the drug Methoxyflurane in the form Liquid for inhalation 999 mg per g, 3 ml (with inhaler))
Insert:
Flagyl | Metronidazole | Suppositories 500 mg, 10 | Rectal |
Carbohydrate Free Mixture | Milk protein and fat formula with vitamins and minerals -- carbohydrate free | Oral powder 225 g (Carbohydrate Free Mixture) | Oral |
MORPHINE SULFATE 15 mg/1 mL MEDSURGE | Morphine | Injection containing morphine sulfate pentahydrate 15 mg in 1 mL | Injection |
MORPHINE SULFATE 30 mg/1 mL MEDSURGE | Morphine | Injection containing morphine sulfate pentahydrate 30 mg in 1 mL | Injection |
Ditropan | Oxybutynin | Tablet containing oxybutynin hydrochloride 5 mg | Oral |
Oxytrol | Oxybutynin | Transdermal patches 36 mg, 8 | Transdermal |
6 Section 5 (after table item dealing with the brand Lyclear of the drug Permethrin in the form Cream 50 mg per g, 30 g)
Insert:
Elidel | Pimecrolimus | Cream 10 mg per g, 15 g | Application |
7 Section 5 (after table item dealing with the brand Pro-Cid of the drug Probenecid in the form Tablet 500 mg)
Insert:
Stemetil | Prochlorperazine | Injection containing prochlorperazine mesilate 12.5 mg in 1 mL | Injection |
Aptamil Gold+ Pepti-Junior | Protein hydrolysate formula with medium chain triglycerides | Oral powder 450 g (Aptamil Gold+ Pepti-Junior) | Oral |
8 Section 5 (after table item dealing with the brand Zempreon CFC-Free with dose counter of the drug Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation))
Insert:
Eldepryl | Selegiline | Tablet containing selegiline hydrochloride 5 mg | Oral |
9 Section 5 (after table item dealing with the brand PHOSPHATE PHEBRA of the drug Sodium acid phosphate in the form Tablet, compound effervescent, equivalent to 500 mg phosphorus)
Insert:
Micolette | Sorbitol with sodium citrate dihydrate and sodium lauryl sulfoacetate | Enemas 3.125 g-450 mg-45 mg in 5 mL, 12 | Rectal |
10 Section 5 (after table item dealing with the brand K.Quik of the drug Triglycerides, medium chain in the form Oral liquid 225 mL, 15 (K.Quik))
Insert:
Epilim Liquid | Valproic acid | Oral liquid containing sodium valproate 200 mg per 5 mL, 300 mL | Oral |
Epilim Syrup | Valproic acid | Oral solution containing sodium valproate 200 mg per 5 mL, 300 mL | Oral |
Schedule 3—Repeals
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2022
1 The whole of the instrument
Repeal the instrument.